Insight

Photo of Hannah Goulart taken from www.researchgate.net

Jun 12, 2024, 15:23

Naveen Pemmaraju: Delighted to share our brand new review paper led by Dr Hannah Goulart

Naveen Pemmaraju recently shared a post on X:

“Delighted to share our brand new review paper at the British Journal of Haematology led by Dr Hannah Goulart.”

Read further
Source: Naveen Pemmaraju/X

Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of the MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.

AYACSM British Journal of Haematology cancer Claire Harrison Hannah Goulart Jean-Jacques Kiladjian Lucia Masarova MPNSM myeloproliferative neoplasms Naveen Pemmaraju OncoDaily Oncology Ruben Mesa

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage